InvestorsHub Logo
Followers 0
Posts 19
Boards Moderated 0
Alias Born 11/19/2013

Re: None

Tuesday, 04/01/2014 5:55:41 PM

Tuesday, April 01, 2014 5:55:41 PM

Post# of 27437
SABAI is right, there are many biotechs that trade at 250million+ market cap and have little to no revenue. Companies like this don't necessarily trade on revenue. They trade on potential market capitalization and growth. Don't be surprised to see CTSO pull in 1 million in the third or fourth quarter and trade at 300-400 million market cap. Biotech stocks that are just starting to commercialize their products rarely trade as you would expect them to.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News